-
公开(公告)号:NZ302649A
公开(公告)日:2000-01-28
申请号:NZ30264996
申请日:1996-02-12
Applicant: BASF AG
Inventor: BOHM HANS-JOACHIM , HOFFKEN HAN WOLFGANG , HORNBERGER WILFRIED , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , ZIERKE THOMAS
IPC: A61K31/00 , A61K38/55 , A61P7/02 , C07D205/04 , C07D207/16 , C07D213/53 , C07D213/63 , C07D213/72 , C07D213/78 , C07D213/79 , C07D239/28 , C07D241/14 , C07D241/24 , C07D401/12 , C07K5/06 , C07K5/062 , C07K5/078 , A61K31/40 , A61K31/445 , A61K31/495
Abstract: he present invention relates to carbo- and heterocyclic amidines, the preparation thereof and the use as thrombin inhibitors of the formula 1 Where D is formula 1a R2 is H, C1-4 alkyl, phenyl and phenyl C1-4 alkyl, R18O-CH2, R18CO- R18-O-CH2-CO-, R18O-CO-CO-, R18-NH-CO-CO, where R18 is H or C1-4-alkyl, CF3-CO- or C2F5-Co- A is formula IIa, IIb or Iic B is selected from IIIa-IIIg The other substituents are defined in the specification.
-
152.
公开(公告)号:ZA9806064B
公开(公告)日:2000-01-10
申请号:ZA9806064
申请日:1998-07-09
Applicant: BASF AG
Inventor: SUBKOWSKI THOMAS , HORNBERGER WILFRIED
IPC: A61K38/00 , A61K39/395 , A61P7/02 , A61P7/04 , A61P39/02 , C07K16/00 , C07K16/40 , C12N5/10 , C12N15/02 , C12P21/08 , G01N33/573 , C07K , A61K , G01N
CPC classification number: G01N33/573 , A61K38/00 , C07K16/40 , G01N2333/96433
-
公开(公告)号:AU708001B2
公开(公告)日:1999-07-29
申请号:AU4875196
申请日:1996-02-12
Applicant: BASF AG
Inventor: BOHM HANS-JOACHIM , HOFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , ZIERKE THOMAS
IPC: A61K31/00 , A61K38/55 , A61P7/02 , C07D205/04 , C07D207/16 , C07D213/53 , C07D213/63 , C07D213/72 , C07D213/78 , C07D213/79 , C07D239/28 , C07D241/14 , C07D241/24 , C07D401/12 , C07K5/06 , C07K5/062 , C07K5/078 , A61K31/40 , A61K31/445 , A61K31/495
Abstract: The invention relates to a compound of the formula I: or a salt thereof with a physiologically tolerated acid, or stereoisomers thereof, wherein R 1 , R 2 , A, B, C and D have the meanings described in the specification.
-
154.
公开(公告)号:HU9800634A2
公开(公告)日:1999-06-28
申请号:HU9800634
申请日:1996-02-06
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , HORNBERGER WILFRIED , HOEFFKEN HANS WOLFGANG , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , ZIERKE THOMAS
Abstract: PCT No. PCT/EP96/00472 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Feb. 6, 1996 PCT Pub. No. WO96/24609 PCT Pub. Date Aug. 15, 1996Thrombin inhibitors of the formula where R1, A, B and D have the meaning indicated in the description, and intermediates for the preparation thereof are described. The compounds I are suitable for controlling diseases.
-
公开(公告)号:AU706834B2
公开(公告)日:1999-06-24
申请号:AU4787596
申请日:1996-02-06
Applicant: BASF AG
Inventor: SEITZ WERNER , MACK HELMUT , ZIERKE THOMAS , BOHM HANS-JOACHIM , HOFFKEN HANS WOLFGANG , KOSER STEFAN , PFEIFFER THOMAS , HORNBERGER WILFRIED
Abstract: PCT No. PCT/EP96/00472 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Feb. 6, 1996 PCT Pub. No. WO96/24609 PCT Pub. Date Aug. 15, 1996Thrombin inhibitors of the formula where R1, A, B and D have the meaning indicated in the description, and intermediates for the preparation thereof are described. The compounds I are suitable for controlling diseases.
-
公开(公告)号:CZ48699A3
公开(公告)日:1999-05-12
申请号:CZ48699
申请日:1997-07-29
Applicant: BASF AG
Inventor: BAUCKE DORIT , LANGE UDO , MACK HELMUT , SEITZ WERNER , ZIERKE THOMAS , HOFFKEN HANS WOLFGANG , HORNBERGER WILFRIED
IPC: A61K38/00 , A61K38/05 , A61P7/02 , A61P29/00 , A61P35/00 , A61P35/04 , C07K5/06 , C07K5/062 , C07K5/065
Abstract: PCT No. PCT/EP97/04104 Sec. 371 Date Feb. 10, 1999 Sec. 102(e) Date Feb. 10, 1999 PCT Filed Jul. 29, 1997 PCT Pub. No. WO98/06741 PCT Pub. Date Feb. 19, 1998Compounds of the formula where A, B, E and D have the meanings indicated in the description, and their preparation are described. The substances are suitable for controlling diseases.
-
公开(公告)号:TR9900310T2
公开(公告)日:1999-04-21
申请号:TR9900310
申请日:1997-07-29
Applicant: BASF AG
Inventor: BAUCKE DORIT , LANGE UDO , MACK HELMUT , SEITZ WERNER , ZIERKE THOMAS , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED
IPC: A61K38/00 , A61K38/05 , A61P7/02 , A61P29/00 , A61P35/00 , A61P35/04 , C07K5/06 , C07K5/062 , C07K5/065
CPC classification number: C07K5/06078 , A61K38/00
-
公开(公告)号:NO990662L
公开(公告)日:1999-02-12
申请号:NO990662
申请日:1999-02-12
Applicant: BASF AG
Inventor: BAUCKE DORIT , LANGE UDO , MACK HELMUT , SEITZ WERNER , ZIERKE THOMAS , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED
IPC: A61K38/00 , A61K38/05 , A61P7/02 , A61P29/00 , A61P35/00 , A61P35/04 , C07K5/06 , C07K5/062 , C07K5/065
Abstract: PCT No. PCT/EP97/04104 Sec. 371 Date Feb. 10, 1999 Sec. 102(e) Date Feb. 10, 1999 PCT Filed Jul. 29, 1997 PCT Pub. No. WO98/06741 PCT Pub. Date Feb. 19, 1998Compounds of the formula where A, B, E and D have the meanings indicated in the description, and their preparation are described. The substances are suitable for controlling diseases.
-
159.
公开(公告)号:CA2295218A1
公开(公告)日:1999-01-21
申请号:CA2295218
申请日:1998-06-23
Applicant: BASF AG
Inventor: SUBKOWSKI THOMAS , HORNBERGER WILFRIED
IPC: A61K38/00 , A61K39/395 , A61P7/02 , A61P7/04 , A61P39/02 , C07K16/00 , C07K16/40 , C12N5/10 , C12N15/02 , C12P21/08 , G01N33/573
Abstract: The invention relates to ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and the use thereof in pharmaceutical preparations or in diagnostics. The invention also relates to cells which express said antibodies, antibody fragments and mixtures or derivatives thereof.
-
公开(公告)号:AU699501B2
公开(公告)日:1998-12-03
申请号:AU2787595
申请日:1995-06-06
Applicant: BASF AG
Inventor: BOHM HANS-JOACHIM , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , HOFFKEN HANS WOLFGANG , HORNBERGER WILFRIED
IPC: A61K31/40 , A61K38/00 , A61K38/05 , A61K38/55 , A61K47/48 , A61P7/02 , C07C279/00 , C07D205/04 , C07D207/06 , C07D207/16 , C07D207/48 , C07D211/60 , C07K5/06 , C07K5/065 , C07K5/072 , C07K5/078
Abstract: Compounds of the formula and the salts thereof with physiologically tolerated acids and the stereoisomers thereof, in which the substituents have the meanings stated in the description, are described. Also disclosed are intermediates for their preparation. The compounds are suitable for controlling diseases.
-
-
-
-
-
-
-
-
-